Arrowstreet Capital, Limited Partnership Neogenomics Inc Transaction History

Arrowstreet Capital, Limited Partnership

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $1.07 Million - $1.54 Million	-25,779 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$36.08 - $56.47 $15 Million - $23.4 Million	-415,053 Reduced 94.15%	25,779 $1.39 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $5.41 Million - $6.58 Million	-162,515 Reduced 26.94%	440,832 $16.3 Million
Q2 2020 Aug 12, 2020	BUY	$24.21 - $31.02 $8.33 Million - $10.7 Million	344,000 Added 132.64%	603,347 $18.7 Million
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $5.32 Million - $8.96 Million	259,347 New	259,347 $7.16 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $2.03 Million - $2.79 Million	-106,395 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $2.08 Million - $2.56 Million	106,395 New	106,395 $2.33 Million
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $3.57 Million - $6.01 Million	-293,890 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $1.12 Million - $1.84 Million	99,525 Added 51.21%	293,890 $3.71 Million
Q3 2018 Nov 14, 2018	BUY	$12.5 - $15.38 $1.56 Million - $1.92 Million	124,822 Added 179.49%	194,365 $2.98 Million
Q2 2018 Aug 14, 2018	BUY	$7.99 - $14.05 $555,648 - $977,079	69,543 New	69,543 $912,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.83B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.